Clinical Management of Infectious Diarrhea

Author(s): Valentina Siciliano*, Enrico Celestino Nista, Tommaso Rosà, Mattia Brigida, Francesco Franceschi

Journal Name: Reviews on Recent Clinical Trials

Volume 15 , Issue 4 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Infectious diarrhea is the most common cause of diarrhea worldwide and is responsible for more deaths than other gastrointestinal tract diseases such as gastrointestinal cancers, peptic ulcer disease or inflammatory bowel disease. Diarrheal disease still represents the 8th leading cause of death worldwide, with more than 1,6 million attributed fatalities in 2016 alone. The majority of cases can be divided into three principal clinical presentations: acute watery diarrhea lasting 5-10 days and normally self-limiting, bloody diarrhea (dysentery), and persistent diarrhea with or without intestinal malabsorption.

Methods: We performed an electronic search on PUBMED of the scientific literature concerning infectious diarrhea and its clinical management.

Aim: In this review article, we analyze the most important causes of infectious diarrhea and their constellation of signs and symptoms, providing an update on the diagnostic tools available in today’s practice and on the different treatment options.

Conclusion: Even though the majority of intestinal infections are self-limiting in immunocompetent individuals, specific diagnosis and identification of the causative agent remain crucial from public health and epidemiological perspectives. Specific diagnostic investigation can be reserved for patients with severe dehydration, more severe illness, persistent fever, bloody stools, immunosuppression, and for cases of suspected nosocomial infection or outbreak and it includes complete blood count, creatinine and electrolytes evaluation, determination of leukocytes and lactoferrin presence in the stools, stool culture, together with C. difficile testing, PCR, ova and parasites' search, endoscopy and abdominal imaging. Since acute diarrhea is most often self-limited and caused by viruses, routine antibiotic use is not recommended for most adults with mild, watery diarrhea. However, when used appropriately, antibiotics are effective against shigellosis, campylobacteriosis, C. difficile colitis, traveler’s diarrhea, and protozoal infections. Furthermore, antibiotics use should be considered in patients who are older than 65 years, immunocompromised, severely ill, or septic.

Keywords: Diarrhea, infectious, infection, dysentery, antibiotics, antimicrobial, stool, c. difficile, microbiota, acute, virus, bacteria, protozoa, rehydration.

[1]
GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018; 18(11): 1211-28.
[http://dx.doi.org/10.1016/S1473-3099(18)30362-1] [PMID: 30243583]
[2]
Dupont HL. Dirrheal desease in the developing world. Infect _Dis clinNorth am 1995; 9 (2): 313-324.
[3]
Hodges K, Gill R. Infectious diarrhea: Cellular and molecular mechanisms. Gut Microbes 2010; 1(1): 4-21.
[http://dx.doi.org/10.4161/gmic.1.1.11036] [PMID: 21327112]
[4]
Subramanya SB, Rajendran VM, Srinivasan P, Nanda Kumar NS, Ramakrishna BS, Binder HJ. Differential regulation of cholera toxin-inhibited Na-H exchange isoforms by butyrate in rat ileum. Am J Physiol Gastrointest Liver Physiol 2007; 293(4): G857-63.
[http://dx.doi.org/10.1152/ajpgi.00462.2006] [PMID: 17690171]
[5]
Lima AAM, Lyerly DM, Wilkins TD, Innes DJ, Guerrant RL. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun 1988; 56(3): 582-8.
[http://dx.doi.org/10.1128/IAI.56.3.582-588.1988] [PMID: 3343050]
[6]
Moore R, Pothoulakis C, LaMont JT, Carlson S, Madara JL. C. difficile toxin A increases intestinal permeability and induces Cl- secretion. Am J Physiol - Gastrointest Liver Physiol 1990; 259(2 Pt 1): G165-72.
[7]
Golin-Bisello F, Bradbury N, Ameen N. STa and cGMP stimulate CFTR translocation to the surface of villus enterocytes in rat jejunum and is regulated by protein kinase G. Am J Physiol - Cell Physiol 2005; 289(3 58-3): 708–16.
[8]
Creydt VP, Miyakawa MF, Martín F, Zotta E, Silberstein C, Ibarra C. The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops. Braz J Med Biol Res 2004; 37(6): 799-808.
[http://dx.doi.org/10.1590/S0100-879X2004000600004] [PMID: 15264022]
[9]
Guttman JA, Samji FN, Li Y, Deng W, Lin A, Finlay BB. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell Microbiol 2007; 9(1): 131-41.
[http://dx.doi.org/10.1111/j.1462-5822.2006.00773.x] [PMID: 16889624]
[10]
Dey I, Keller K, Belley A, Chadee K. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc Natl Acad Sci USA 2003; 100(23): 13561-6.
[http://dx.doi.org/10.1073/pnas.1835863100] [PMID: 14585927]
[11]
Aranda-Michel J, Giannella RA. Aranda-MichelJ. Acute diarrhea: A practical review. Am J Med 1999; 106(6): 670-6.
[http://dx.doi.org/10.1016/S0002-9343(99)00128-X] [PMID: 10378626]
[12]
Shah MP, Hall AJ. Norovirus illnesses in children and adolescents. Infect Dis Clin North Am 2018; 32(1): 103-18.
[http://dx.doi.org/10.1016/j.idc.2017.11.004] [PMID: 29406972]
[13]
Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361(18): 1776-85.
[http://dx.doi.org/10.1056/NEJMra0804575] [PMID: 19864676]
[14]
Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of norovirus in cases of gastroenteritis: A systematic review and meta-analysis. Lancet Infect Dis 2014; 14(8): 725-30.
[http://dx.doi.org/10.1016/S1473-3099(14)70767-4] [PMID: 24981041]
[15]
Greenberg HB, Estes MK. Rotaviruses: From pathogenesis to vaccination. Gastroenterology 2009; 136(6): 1939-51.
[http://dx.doi.org/10.1053/j.gastro.2009.02.076] [PMID: 19457420]
[16]
Wood DJ. Adenovirus gastroenteritis. Br Med J (Clin Res Ed) 1988; 296(6617): 229-30.
[http://dx.doi.org/10.1136/bmj.296.6617.229-a] [PMID: 2829987]
[17]
Celik C, Gozel MG, Turkay H, Bakici MZ, Güven AS, Elaldi N. Rotavirus and adenovirus gastroenteritis: Time series analysis. Pediatr Int 2015; 57(4): 590-6.
[http://dx.doi.org/10.1111/ped.12592] [PMID: 25625610]
[18]
Taneja N, Zaman K. Clostridium difficile associated diarrhea: Diagnostic challenges. J Assoc Physicians India 2018; 66(6): 70-3.
[PMID: 31331140]
[19]
Guery B, Galperine T, Barbut F. Clostridioides difficile: Diagnosis and treatments. BMJ 2019; 366: l4609.
[http://dx.doi.org/10.1136/bmj.l4609] [PMID: 31431428]
[20]
Saha S, Khanna S. Management of Clostridioides difficile colitis: Insights for the gastroenterologist. Therap Adv Gastroenterol 2019; 12: 1756284819847651.
[http://dx.doi.org/10.1177/1756284819847651] [PMID: 31105766]
[21]
Feasey NA, Healey P, Gordon MA. Review article: The aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 2011; 34(6): 587-603.
[http://dx.doi.org/10.1111/j.1365-2036.2011.04781.x] [PMID: 21777262]
[22]
Logan C, Beadsworth MB, Beeching NJ. HIV and diarrhoea: What is new? Curr Opin Infect Dis 2016; 29(5): 486-94.
[http://dx.doi.org/10.1097/QCO.0000000000000305] [PMID: 27472290]
[23]
Leung AKC, Leung AAM, Wong AHC, Hon KL. Travelers’ diarrhea: A clinical review. Recent Pat Inflamm Allergy Drug Discov 2019; 13(1): 38-48.
[http://dx.doi.org/10.2174/1872213X13666190514105054] [PMID: 31084597]
[24]
Sell J, Dolan B. Common gastrointestinal infections. Prim Care 2018; 45(3): 519-32.
[http://dx.doi.org/10.1016/j.pop.2018.05.008] [PMID: 30115338]
[25]
Steffen R, Hill DR, DuPont HL. Traveler’s diarrhea: A clinical review. JAMA 2015; 313(1): 71-80.
[http://dx.doi.org/10.1001/jama.2014.17006] [PMID: 25562268]
[26]
Farthing MJG. Dehydration and rehydratation in children.Hydration throughout fife. Paris: John Libbey -eurotext 1998; pp. 159-73.
[27]
DuPont HL. The Practice Parameters Committee of the American College of Gastroenterology. Guidelines on acute infectious diarrhea in adults. Am J Gastroenterol 1997; 92(11): 1962-75.
[PMID: 9362174]
[28]
Ali MA, Arnold CA, Singhi AD, Voltaggio L. Clues to uncommon and easily overlooked infectious diagnoses af-fecting the GI tract and distinction from their clinicopathologic mimics. Endosc 2014; 80(4): 689-706.
[29]
Espinosa-Cantellano M, Martínez-Palomo A. Pathogenesis of intestinal amebiasis: From molecules to disease. Clin Microbiol Rev 2000; 13(2): 318-31.
[http://dx.doi.org/10.1128/CMR.13.2.318] [PMID: 10756002]
[30]
Stanley SL Jr. Amoebiasis. Lancet 2003; 361(9362): 1025-34.
[http://dx.doi.org/10.1016/S0140-6736(03)12830-9] [PMID: 12660071]
[31]
Guerrant RL, Van Gilder T, Steiner TS, et al. Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32(3): 331-51.
[http://dx.doi.org/10.1086/318514] [PMID: 11170940]
[32]
Farthing M_salm , MALindberg G, et al. WorldGastroenterology organisation. Acute diarrhea in adults and children: A global prospective. J clan -gastroenetrol 2013; 47(1): 12-20.
[33]
Gill CJ, Lau J. -gorbach SL, Hamer DH. -diagnostic acuracy of stool assay for inflammatory bacterial gastroen-teritis in delevoop and resource poor country. Clan. Infect Dis 2003; 37(3): 365-75.
[http://dx.doi.org/10.1086/375896] [PMID: 12884161]
[34]
Chen CC. chang CJ, Lin TY, Lai MV, Chao HC, Kong MS. Usefulness of fecal lactoferrin in predicting and moni-toring the clinical severity of infectious diarrhea. World J Gastroenterol 2011; 17(37): 4218-24.
[http://dx.doi.org/10.3748/wjg.v17.i37.4218] [PMID: 22072854]
[35]
LaSala PR, Ekhmimi T, Hill AK, Farooqi I, Perrotta PL. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens. J Clin Microbiol 2013; 51(1): 311-3.
[http://dx.doi.org/10.1128/JCM.02735-12] [PMID: 23135940]
[36]
Hayakawa T, Jin CX, Ko SB, Kitagawa M, Ishiguro H. Lactoferrin in gastrointestinal disease. Intern Med 2009; 48(15): 1251-4.
[http://dx.doi.org/10.2169/internalmedicine.48.2199] [PMID: 19652425]
[37]
Bauer TM, Lalvani A, Fehrenbach J, et al. Derivation and validation of guidelines for stool cultures for enterophatogenic bacteria other Clostridium difficile in hospitalized adult. JAMA 2001; 285(83): 313-319.
[38]
Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R. Etiological agents of infectious diarrhea: Implications for requests for microbial culture. J Clin Microbiol 1997; 35(6): 1427-32.
[http://dx.doi.org/10.1128/JCM.35.6.1427-1432.1997] [PMID: 9163457]
[39]
Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012; 61(9): 157-62.
[PMID: 22398844]
[40]
Liu J, Gratz J, Maro A, et al. Simultaneous detection of six diarrhea-causing bacterial pathogens with an in-house PCR-luminex assay. J Clin Microbiol 2012; 50(1): 98-103.
[http://dx.doi.org/10.1128/JCM.05416-11] [PMID: 22075596]
[41]
Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: A meta-analysis. Clin Infect Dis 2011; 53(7): e81-90.
[http://dx.doi.org/10.1093/cid/cir505] [PMID: 21890762]
[42]
Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules. Appl Environ Microbiol 2012; 78(15): 5111-8.
[http://dx.doi.org/10.1128/AEM.07990-11] [PMID: 22582062]
[43]
Verweij JJ, Schinkel J, Laeijendecker D, van Rooyen MA, van Lieshout L, Polderman AM. Real-time PCR for the detection of Giardia lamblia. Mol Cell Probes 2003; 17(5): 223-5.
[http://dx.doi.org/10.1016/S0890-8508(03)00057-4] [PMID: 14580396]
[44]
Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990; 263(7): 979-82.
[http://dx.doi.org/10.1001/jama.1990.03440070067034] [PMID: 2299766]
[45]
Shane AL, Mody RK, Crump JA, et al. 2017 Infectious diseases society of america clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis 2017; 65(12): e45-80.
[http://dx.doi.org/10.1093/cid/cix669] [PMID: 29053792]
[46]
Tanyuksel M, Petri WA Jr. Laboratory diagnosis of amebiasis. Clin Microbiol Rev 2003; 16(4): 713-29.
[http://dx.doi.org/10.1128/CMR.16.4.713-729.2003] [PMID: 14557296]
[47]
Ahmed SA, Karanis P. Comparison of current methods used to detect Cryptosporidium oocysts in stools. Int J Hyg Environ Health 2018; 221(5): 743-63.
[http://dx.doi.org/10.1016/j.ijheh.2018.04.006] [PMID: 29776848]
[48]
Adeyemo FE, Singh G, Reddy P, Stenström TA. Methods for the detection of Cryptosporidium and Giardia: From microscopy to nucleic acid based tools in clinical and environmental regimes. Acta Trop 2018; 184: 15-28.
[http://dx.doi.org/10.1016/j.actatropica.2018.01.011] [PMID: 29395034]
[49]
Shen B, Khan K, Ikenberry SO, et al. ASGE Standards of Practice Committee. The role of endoscopy in the management of patients with diar- rhea. Gastrointest Endosc 2010; 71(6): 887-92.
[http://dx.doi.org/10.1016/j.gie.2009.11.025] [PMID: 20346452]
[50]
Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates acute self-limited colitis from ulcerative colitis. Gastroenterology 1987; 92(2): 318-28.
[http://dx.doi.org/10.1016/0016-5085(87)90124-7] [PMID: 3792768]
[51]
Allison MC, Hamilton-Dutoit SJ, Dhillon AP, Pounder RE. The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med 1987; 65(248): 985-95.
[PMID: 3455554]
[52]
Tedesco FJ, Hardin RD, Harper RN, Edwards BH. Infectious colitis endoscopically simulating inflammatory bowel disease: A prospective evaluation. Gastrointest Endosc 1983; 29(3): 195-7.
[http://dx.doi.org/10.1016/S0016-5107(83)72583-6] [PMID: 6618115]
[53]
Surawicz CM. Diagnosing colitis. Biopsy is best. Gastroenterology 1987; 92(2): 538-40.
[http://dx.doi.org/10.1016/0016-5085(87)90156-9] [PMID: 3792790]
[54]
Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010; 16(10): 1245-51.
[http://dx.doi.org/10.3748/wjg.v16.i10.1245] [PMID: 20222169]
[55]
Bhargava DK, Tandon HD, Chawla TC, Shriniwas , Tandon BN, Kapur BM. Diagnosis of ileocecal and colonic tuberculosis by colonoscopy. Gastrointest Endosc 1985; 31(2): 68-70.
[http://dx.doi.org/10.1016/S0016-5107(85)71995-5] [PMID: 3922847]
[56]
Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol 2010; 105(3): 642-51.
[http://dx.doi.org/10.1038/ajg.2009.585] [PMID: 20087333]
[57]
Coremans G, Rutgeerts P, Geboes K, Van den Oord J, Ponette E, Vantrappen G. The value of ileoscopy with biopsy in the diagnosis of intestinal Crohn’s disease. Gastrointest Endosc 1984; 30(3): 167-72.
[http://dx.doi.org/10.1016/S0016-5107(84)72358-3] [PMID: 6735093]
[58]
Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: Inflammatory disease. Radiographics 2000; 20(2): 399-418.
[http://dx.doi.org/10.1148/radiographics.20.2.g00mc15399] [PMID: 10715339]
[59]
Sunakorn P. Oral electrolyte therapy for acute diarrhea in infants. J Med Assoc Thai 1981; 64(8): 401-5.
[PMID: 7264496]
[60]
International Study Group on Reduced-Osmolality ORS Solutions. Multicentre evaluation of reduced-osmolality oral rehydration salts solution. Lancet 1995; 346: 282-5.
[61]
Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol 2005; 5(6): 559-65.
[http://dx.doi.org/10.1016/j.coph.2005.08.002] [PMID: 16207535]
[62]
Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler’s diarrhea: A systematic review and meta-analysis. Clin Infect Dis 2008; 47(8): 1007-14.
[http://dx.doi.org/10.1086/591703] [PMID: 18781873]
[63]
Salminen S, von Wright A, Morelli L, et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998; 44(1-2): 93-106.
[http://dx.doi.org/10.1016/S0168-1605(98)00128-7] [PMID: 9849787]
[64]
Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; (11): CD003048
[http://dx.doi.org/10.1002/14651858.CD003048.pub3] [PMID: 21069673]
[65]
Hui W, Li T, Liu W, Zhou C, Gao F. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. PLoS One 2019; 14(1): e0210016.
[http://dx.doi.org/10.1371/journal.pone.0210016] [PMID: 30673716]
[66]
Tariq R, Pardi DS, Bartlett MG, Khanna S. Low cure rates in controlled trials of fecal microbiota transplantation for recurrent Clostridium difficile infection: A systematic review and meta-analysis. Clin Infect Dis 2019; 68(8): 1351-8.
[http://dx.doi.org/10.1093/cid/ciy721] [PMID: 30957161]
[67]
Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: Pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72(6): 1516-22.
[http://dx.doi.org/10.1093/ajcn/72.6.1516] [PMID: 11101480]
[68]
Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342(26): 1930-6.
[http://dx.doi.org/10.1056/NEJM200006293422601] [PMID: 10874060]
[69]
European Medicine agency. Disabling and potentially permanent side effects lead to suspension or restriction of quinolone and fluoroquinolone antibiotics. EMA/175398/2019. https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products Accessed Jan 15th 2020
[70]
Ordóñez-Mena JM, McCarthy ND, Fanshawe TR. Comparative efficacy of drugs for treating giardiasis: A systematic update of the literature and network meta-analysis of randomized clinical trials. J Antimicrob Chemother 2018; 73(3): 596-606.
[http://dx.doi.org/10.1093/jac/dkx430] [PMID: 29186570]
[71]
Gonzales MLM, Dans LF, Sio-Aguilar J. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev 2019; 1(1): CD006085.
[http://dx.doi.org/10.1002/14651858.CD006085.pub3] [PMID: 30624763]
[72]
Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol 2006; 4(3): 320-4.
[http://dx.doi.org/10.1016/j.cgh.2005.12.020] [PMID: 16527695]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 4
Year: 2020
Published on: 28 June, 2020
Page: [298 - 308]
Pages: 11
DOI: 10.2174/1574887115666200628144128
Price: $65

Article Metrics

PDF: 29
HTML: 2